The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
An Update on Randomized Clinical Trials in Hepatocellular Carcinoma
Sim HW1, Knox J1, Dawson LA2. Surg Oncol Clin N Am. 2017 Oct;26(4):647-666. doi: 10.1016/j.soc.2017.05.006. Epub 2017 Aug 4.
Author information
1
Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada.
2
Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada. Electronic address: Laura.Dawson@rmp.uhn.on.ca.
Abstract
Hepatocellular carcinoma is a common malignancy that typically occurs in the setting of comorbid liver disease. Optimal management is challenging, especially given the assortment of available treatment modalities. This article reviews the randomized clinical trials that have formed the basis of contemporary hepatocellular carcinoma management.